Your Sorted CME/CE Activities


Quarterly Brief (July-September, 2018): A Current Expert Analysis on Important HIV Clinical Decisions
Certified CME/CNE/CPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

These educational Quarterly Briefs will discuss changing guidelines, evolving treatment options, and side-effect considerations in the management of patients with HIV.
Review this Quarterly Brief and claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of the brief Post-Test/Evaluation.








Ask the Expert
Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Guest Faculty
Eric Daar, MD Eric Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA

20
Supported by an independent educational grant from ViiV Healthcare.
September 30, 2019
Mini Module
6201
QuarterlyBrief_WebBanner_1158.gif
HIV